Lysosomal Storage Disorders Shed Light on Lysosomal Dysfunction in Parkinson’s Disease
The lysosome is a central player in the cell, acting as a clearing house for macromolecular degradation, but also plays a critical role in a variety of additional metabolic and regulatory processes. The lysosome has recently attracted the attention of neurobiologists and neurologists since a number...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/14/4966 |
id |
doaj-953b814297e84e0e8328846ec0fce44a |
---|---|
record_format |
Article |
spelling |
doaj-953b814297e84e0e8328846ec0fce44a2020-11-25T03:02:25ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-07-01214966496610.3390/ijms21144966Lysosomal Storage Disorders Shed Light on Lysosomal Dysfunction in Parkinson’s DiseaseShani Blumenreich0Or B. Barav1Bethan J. Jenkins2Anthony H. Futerman3Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 76100, IsraelDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 76100, IsraelDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 76100, IsraelDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 76100, IsraelThe lysosome is a central player in the cell, acting as a clearing house for macromolecular degradation, but also plays a critical role in a variety of additional metabolic and regulatory processes. The lysosome has recently attracted the attention of neurobiologists and neurologists since a number of neurological diseases involve a lysosomal component. Among these is Parkinson’s disease (PD). While heterozygous and homozygous mutations in <i>GBA1</i> are the highest genetic risk factor for PD, studies performed over the past decade have suggested that lysosomal loss of function is likely involved in PD pathology, since a significant percent of PD patients have a mutation in one or more genes that cause a lysosomal storage disease (LSD). Although the mechanistic connection between the lysosome and PD remains somewhat enigmatic, significant evidence is accumulating that lysosomal dysfunction plays a central role in PD pathophysiology. Thus, lysosomal dysfunction, resulting from mutations in lysosomal genes, may enhance the accumulation of α-synuclein in the brain, which may result in the earlier development of PD.https://www.mdpi.com/1422-0067/21/14/4966lysosomal storage diseasesParkinson’s diseaseGaucher diseaseα-synuclein |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shani Blumenreich Or B. Barav Bethan J. Jenkins Anthony H. Futerman |
spellingShingle |
Shani Blumenreich Or B. Barav Bethan J. Jenkins Anthony H. Futerman Lysosomal Storage Disorders Shed Light on Lysosomal Dysfunction in Parkinson’s Disease International Journal of Molecular Sciences lysosomal storage diseases Parkinson’s disease Gaucher disease α-synuclein |
author_facet |
Shani Blumenreich Or B. Barav Bethan J. Jenkins Anthony H. Futerman |
author_sort |
Shani Blumenreich |
title |
Lysosomal Storage Disorders Shed Light on Lysosomal Dysfunction in Parkinson’s Disease |
title_short |
Lysosomal Storage Disorders Shed Light on Lysosomal Dysfunction in Parkinson’s Disease |
title_full |
Lysosomal Storage Disorders Shed Light on Lysosomal Dysfunction in Parkinson’s Disease |
title_fullStr |
Lysosomal Storage Disorders Shed Light on Lysosomal Dysfunction in Parkinson’s Disease |
title_full_unstemmed |
Lysosomal Storage Disorders Shed Light on Lysosomal Dysfunction in Parkinson’s Disease |
title_sort |
lysosomal storage disorders shed light on lysosomal dysfunction in parkinson’s disease |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1661-6596 1422-0067 |
publishDate |
2020-07-01 |
description |
The lysosome is a central player in the cell, acting as a clearing house for macromolecular degradation, but also plays a critical role in a variety of additional metabolic and regulatory processes. The lysosome has recently attracted the attention of neurobiologists and neurologists since a number of neurological diseases involve a lysosomal component. Among these is Parkinson’s disease (PD). While heterozygous and homozygous mutations in <i>GBA1</i> are the highest genetic risk factor for PD, studies performed over the past decade have suggested that lysosomal loss of function is likely involved in PD pathology, since a significant percent of PD patients have a mutation in one or more genes that cause a lysosomal storage disease (LSD). Although the mechanistic connection between the lysosome and PD remains somewhat enigmatic, significant evidence is accumulating that lysosomal dysfunction plays a central role in PD pathophysiology. Thus, lysosomal dysfunction, resulting from mutations in lysosomal genes, may enhance the accumulation of α-synuclein in the brain, which may result in the earlier development of PD. |
topic |
lysosomal storage diseases Parkinson’s disease Gaucher disease α-synuclein |
url |
https://www.mdpi.com/1422-0067/21/14/4966 |
work_keys_str_mv |
AT shaniblumenreich lysosomalstoragedisordersshedlightonlysosomaldysfunctioninparkinsonsdisease AT orbbarav lysosomalstoragedisordersshedlightonlysosomaldysfunctioninparkinsonsdisease AT bethanjjenkins lysosomalstoragedisordersshedlightonlysosomaldysfunctioninparkinsonsdisease AT anthonyhfuterman lysosomalstoragedisordersshedlightonlysosomaldysfunctioninparkinsonsdisease |
_version_ |
1724689657034178560 |